Strides Pharma Science Limited (BOM:532531)
India · Delayed Price · Currency is INR 992.05
+35.05 (3.66%)
At close: Aug 20, 2026
Strides Pharma Science Employees
Strides Pharma Science had 3,535 employees as of March 31, 2026. The number of employees increased by 234 or 7.09% compared to the previous year.
Employees
3,535
Change (1Y)
234
Growth (1Y)
7.09%
Revenue / Employee
14.16M INR
Profits / Employee
1.74M INR
Market Cap
88.26B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 3,535 | 234 | 7.09% |
| Mar 31, 2025 | 3,301 | 236 | 7.70% |
| Mar 31, 2024 | 3,065 | 215 | 7.54% |
| Mar 31, 2023 | 2,850 | 203 | 7.67% |
| Mar 31, 2022 | 2,647 | 257 | 10.75% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| FDC Limited | 6,857 |
| Jubilant Pharmova | 5,657 |
| CORONA Remedies | 5,153 |
| Viyash Scientific | 2,900 |
| Morepen Laboratories | 1,814 |
| Gufic Biosciences | 1,484 |
| Procter & Gamble Health | 1,326 |
| Sanofi India | 1,097 |
Strides Pharma Science News
- 20 days ago - Strides Pharma Science Transcript: Q1 26/27 - Transcripts
- 20 days ago - Strides Pharma Science Quarterly report: Q1 2027 - Filings
- 20 days ago - Strides Pharma Science Slides: Q1 2027 - Filings
- 7 weeks ago - Strides partners with Ascent Capital valuing Pivot Path at ₹2,300 million - Business Upturn
- 3 months ago - Strides Pharma Science Transcript: Q4 25/26 - Transcripts
- 3 months ago - Strides Pharma Science Quarterly report: Q4 2026 - Filings
- 3 months ago - Strides Pharma Science Slides: Q4 2026 - Filings
- 3 months ago - Strides Pharma Science Annual report: Q4 2026 - Filings